Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 31-May-24 9:36 PM View:  | Y-Mabs Therapeutics, Inc. (YMAB) | 31-May-24 | Option Exercise | 31,371 | $2.00 | $62,742.00 | 15% 210.88K to 242.25K | |
| 31-May-24 9:36 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 31-May-24 | Option Sale | 31,371 | $12.07 | $378,648.00 | (13%) 242.25K to 210.88K | |
| 31-May-24 9:36 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 30-May-24 | Option Exercise | 28,629 | $2.00 | $57,258.00 | 14% 210.88K to 239.51K | |
| 31-May-24 9:36 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 30-May-24 | Option Sale | 28,629 | $12.03 | $344,407.00 | (12%) 239.51K to 210.88K | |
| 22-Jan-24 5:48 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 18-Jan-24 | Grant | 18,100 | -- | -- | 9% 192.78K to 210.88K | |
| 19-Jan-23 4:34 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 17-Jan-23 | Grant | 11,700 | -- | -- | 6% 181.08K to 192.78K | |
| 23-Feb-22 10:00 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 22-Feb-22 | Sale (Planned) | 4,000 | $7.85 | $31,400.00 | (2%) 185.08K to 181.08K | |
| 07-Feb-22 5:16 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 04-Feb-22 | Sale (Planned) | 4,000 | $7.97 | $31,880.00 | (2%) 189.08K to 185.08K | |
| 25-Jan-22 5:01 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 24-Jan-22 | Sale (Planned) | 4,000 | $9.84 | $39,360.00 | (2%) 193.08K to 189.08K | |
| 05-Jan-22 5:15 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 04-Jan-22 | Market Sale (Planned) | 4,000 | $17.12 | $68,480.00 | (2%) 197.08K to 193.08K | 4% |
| 23-Dec-21 4:55 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 22-Dec-21 | Market Sale (Planned) | 4,000 | $16.36 | $65,440.00 | (2%) 201.08K to 197.08K | (5%) |
| 07-Dec-21 5:16 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 06-Dec-21 | Market Sale (Planned) | 4,000 | $16.35 | $65,400.00 | (2%) 205.08K to 201.08K | (1%) |
| 23-Nov-21 5:06 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 22-Nov-21 | Market Sale (Planned) | 4,000 | $18.09 | $72,360.00 | (2%) 209.08K to 205.08K | 4% |
| 05-Nov-21 5:16 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 04-Nov-21 | Market Sale (Planned) | 4,000 | $27.54 | $110,160.00 | (2%) 213.08K to 209.08K | 14% |
| 26-Oct-21 6:04 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 22-Oct-21 | Market Sale (Planned) | 4,000 | $25.94 | $103,760.00 | (2%) 217.08K to 213.08K | < 1% |
| 05-Oct-21 5:16 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 04-Oct-21 | Market Sale (Planned) | 4,000 | $28.78 | $115,120.00 | (2%) 221.08K to 217.08K | 5% |
| 23-Sep-21 10:00 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 22-Sep-21 | Market Sale (Planned) | 4,000 | $30.82 | $123,280.00 | (2%) 225.08K to 221.08K | 7% |
| 08-Sep-21 5:31 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 07-Sep-21 | Market Sale (Planned) | 4,000 | $32.03 | $128,120.00 | (2%) 229.08K to 225.08K | < 1% |
| 26-Jul-21 6:19 AM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 22-Jul-21 | Market Sale (Planned) | 4,000 | $34.50 | $138,000.00 | (2%) 241.08K to 237.08K | (2%) |
| 07-Jul-21 6:00 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 06-Jul-21 | Market Sale (Planned) | 4,000 | $34.15 | $136,600.00 | (2%) 245.08K to 241.08K | 5% |
| 23-Jun-21 4:30 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 22-Jun-21 | Market Sale (Planned) | 4,000 | $36.17 | $144,680.00 | (2%) 249.08K to 245.08K | 6% |
| 07-Jun-21 4:30 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 04-Jun-21 | Market Sale (Planned) | 4,000 | $33.48 | $133,920.00 | (2%) 253.08K to 249.08K | < 1% |
| 26-May-21 4:33 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 24-May-21 | Market Sale (Planned) | 4,000 | $35.61 | $142,440.00 | (2%) 257.08K to 253.08K | (1%) |
| 15-May-20 4:15 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 14-May-20 | Market Sale | 28,199 | $36.03 | $1,015,870.00 | (9%) 323.12K to 294.92K | (49%) |
| 15-May-20 4:15 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 14-May-20 | Market Sale | 37,847 | $36.03 | $1,363,530.00 | (13%) 294.92K to 257.08K | (48%) |
| 15-May-20 4:15 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 13-May-20 | Market Sale | 14,724 | $37.86 | $557,517.00 | (4%) 357.08K to 342.35K | (41%) |
| 15-May-20 4:15 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 13-May-20 | Market Sale | 19,230 | $37.88 | $728,400.00 | (6%) 342.35K to 323.12K | (41%) |